Hyaluronic acid: the scientific and clinical evidence

被引:291
作者
Price, Richard D.
Berry, M. G.
Navsaria, Harshad A.
机构
[1] Addenbrookes Hosp, Cambridge, England
[2] Univ London, London Sch Med & Dent, Ctr Cutaneous Res, London E1 2AT, England
[3] Royal Prince Alfred Hosp, Sydney, NSW, Australia
关键词
hyaluronic acid; tissue engineering; fillers;
D O I
10.1016/j.bjps.2007.03.005
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hyaluronic acid is a naturally occurring biopolymer whose molecular structure is highly conserved between mammalian species. First described in 1934, it has since been used across a wide variety of medical fields as diverse as neurosurgery and cutaneous wound heating. Presently it has reached prominence in cosmetic practice where it is now the injectable dermal. filter of choice for most surgeons. We used our experience of this technology with searches in the English language literature for the purpose of a systematic review. We present an overview, including the scientific evidence for its use in wound heating and, briefly, in other fields. We summarise the evidence for and against hyaluronic acid and provide a resume of the current technologies available in fields such as skin regeneration and wound heating, in addition to cosmetic surgery. This overview is not intended to teach the reader about the various formulations currently on the market or how to use these materials clinically - rather to provide a solid scientific background enabling the reader to understand the attributes (and otherwise) of the material. We hope to allow clinicians to assess the evidence for a material now in common use in order that they may be fully aware of its properties. (c) 2007 Published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic Surgeons.
引用
收藏
页码:1110 / 1119
页数:10
相关论文
共 91 条
[1]  
Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO
[2]  
2-M
[3]  
Allemann M, 2001, J BIOMED MATER RES, V55, P13
[4]   Engineering of osteochondral tissue with bone marrow mesenchymal progenitor: Cells in a derivatized hyaluronan-gelatin composite sponge [J].
Angele, P ;
Kujat, R ;
Nerlich, M ;
Yoo, J ;
Goldberg, V ;
Johnstone, B .
TISSUE ENGINEERING, 1999, 5 (06) :545-553
[5]   Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjogren's syndrome patients [J].
Aragona, P ;
Di Stefano, G ;
Ferreri, F ;
Spinella, R ;
Stilo, A .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (08) :879-884
[6]   Hydroxyapatite-collagen-hyaluronic acid composite [J].
Bakos, D ;
Soldán, M ;
Hernández-Fuentes, I .
BIOMATERIALS, 1999, 20 (02) :191-195
[7]   INTERACTION BETWEEN CD44 AND HYALURONATE IS DIRECTLY IMPLICATED IN THE REGULATION OF TUMOR-DEVELOPMENT [J].
BARTOLAZZI, A ;
PEACH, R ;
ARUFFO, A ;
STAMENKOVIC, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :53-66
[8]   Primary repair and intraocular lens implantation after perforating eye injury [J].
Baykara, M ;
Dogru, M ;
Özçetin, H ;
Ertürk, H .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2002, 28 (10) :1832-1835
[9]   PRODUCTION OF A TISSUE-LIKE STRUCTURE BY CONTRACTION OF COLLAGEN LATTICES BY HUMAN-FIBROBLASTS OF DIFFERENT PROLIFERATIVE POTENTIAL INVITRO [J].
BELL, E ;
IVARSSON, B ;
MERRILL, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (03) :1274-1278
[10]   HYALURONIDASE AS AN ANTIDOTE TO EXTRAVASATION OF VINCA ALKALOIDS - CLINICAL-RESULTS [J].
BERTELLI, G ;
DINI, D ;
FORNO, GB ;
GOZZA, A ;
SILVESTRO, S ;
VENTURINI, M ;
ROSSO, R ;
PRONZATO, P .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1994, 120 (08) :505-506